Evidence map›Paper›PMID 36530288›Full record

ArticleACS omega2022

Acrylamide: New Organic Solvent with Chemically Tunable Viscosity for Rapid Gram-Scale Synthesis of Gold Nanoparticles.

Yoon Hyuck Kim, Jae-Seung Lee

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yoon Hyuck KimDepartment of Materials Science and Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.
Jae-Seung LeeDepartment of Materials Science and Engineering, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.ORCID https://orcid.org/0000-0002-4077-2043
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noble metal nanoparticles have demonstrated various biomedical, optical, and electronic applications owing to their unique chemical and physical properties. However, their gram-scale synthesis remains a challenge. We have developed a method for the gram-scale synthesis of gold nanoparticles (AuNPs) using acrylamide (AAm) as a solvent. AAm possesses unique properties such as low melting temperature, high solvating power, and high solubility of its polymer (polyacrylamide(pAAm)) in water. The viscosity of the AAm solvent can be chemically tuned by the polymerization of AAm and addition of a low-volatile diluent, which can stabilize highly concentrated as-synthesized AuNPs in gram quantities. The synthesized AuNPs are substantially stable and catalytically active under high ionic strength conditions owing to the pAAm protection on the particle surface. Further, the synthesis mechanism of the AuNPs has been thoroughly investigated. The versatility of the synthesis method is proved by synthesizing other mono-(Ag and Pd) and bimetallic (Au + Pd and Ag + Pd) nanoparticles using the AAm solvent with controlled viscosity. Importantly, the productivity of this synthetic strategy is the highest among the previously reported gram-scale synthesis methods of AuNPs. To the best of our knowledge, our study presents the use of acrylic monomer as a solvent for the gram-scale synthesis of noble metal nanoparticles for the first time. This study significantly extends the list of solvents with chemically tunable viscosity by including other acrylic reagents for nanomaterial synthesis, functionalization, and catalytic, optical, and electrical reactions under highly localized reaction conditions.

Identifiers

PMID36530288
PMCPMC9753545
OpenAlexW4311378115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.